Hospital Universitari Vall d´Hebron -Instituto de Investigacion Oncologica Vall dHebron (VHIO)

Barcelona, Spain

0 studies enrolling now · 1 studies all time

What they study most

Squamous NSCLC

Studies at this site

• Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) — Withdrawn before enrolling